FDA Seeks to Remove Oral Phenylephrine From Decongestants
The US Food and Drug Administration (FDA) is considering removal of oral phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter (OTC) cold medications—including DayQuil, Theraflu, and Sudafed—after an extensive review of available data determined a lack of efficacy.
Authors
- Samantha Anderer
Publication Details
- Journal
- JAMA
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1001/jama.2024.25504
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00